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ABSTRACT
The activation, or maturation, of dendritic cells
(DCs) is crucial for the initiation of adaptive T-
cell mediated immune responses. Research on
the molecular mechanisms implicated in DC mat-
uration has focused primarily on inducible gene-
expression events promoting the acquisition of
new functions, such as cytokine production and
enhanced T-cell-stimulatory capacity. In contrast,
mechanisms that modulate DC function by induc-
ing widespread gene-silencing remain poorly un-
derstood. Yet the termination of key functions is
known to be critical for the function of activated DCs.
Genome-wide analysis of activation-induced histone
deacetylation, combined with genome-wide quan-
tification of activation-induced silencing of nascent
transcription, led us to identify a novel inducible
transcriptional-repression pathway that makes ma-
jor contributions to the DC-maturation process. This
silencing response is a rapid primary event dis-
tinct from repression mechanisms known to oper-
ate at later stages of DC maturation. The repressed
genes function in pivotal processes––including
antigen-presentation, extracellular signal detection,
intracellular signal transduction and lipid-mediator
biosynthesis––underscoring the central contribu-
tion of the silencing mechanism to rapid reshaping
of DC function. Interestingly, promoters of the re-
pressed genes exhibit a surprisingly high frequency
of PU.1-occupied sites, suggesting a novel role for
this lineage-specific transcription factor in marking
genes poised for inducible repression.
INTRODUCTION
Dendritic cells (DCs) are professional antigen (Ag) pre-
senting cells playing central roles in the initiation, reg-
ulation and implementation of Ag-specific immune re-
sponses (1,2). They serve as interfaces between innate
and adaptive immunity by promoting the development
of appropriate T cell responses in response to signals
associated with infection, including pathogen associated
molecular patterns (PAMPs), endogenous danger signals
(DAMPs) and inflammatory signals. Exposure of DCs to
these stimuli triggers a maturation process involving mul-
tiple morphological, phenotypic and functional changes
(1,3). Major changes include increased Major Histocom-
patibility Complex class II (MHCII) expression, increased
Ag-presentation, enhanced costimulatory-molecule expres-
sion, potentiated T-cell-stimulatory capacity, the produc-
tion of pro-inflammatory and/or anti-inflammatory medi-
ators, and altered migratory properties (1,3).
DCs detect PAMPs and DAMPs via pattern recognition
receptors (PRRs), including Toll-like receptors (TLRs),
Nod-like receptors (NLRs), C-type lectin receptors (CLRs)
and Rig-I-like receptors (RLRs) (4,5). PRR-engagement
activates well-defined signaling cascades that induce com-
plex transcriptional responses adapted to the stimuli that
elicited them (6–9). Current knowledge on regulatory net-
works governing transcriptional responses in DCs is largely
derived from genome-wide transcriptomic, epigenetic and
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transcription factor (TF) binding studies performed with
mouse bone marrow derived DCs (BM-DCs), and primary
cells or cell lines belonging to the monocyte-macrophage
lineage (6–9). These studies focused primarily on tran-
scriptional activation. Current models propose that PRR-
induced signaling converges on signal-activated TFs, some-
times referred to as class I TFs, including members of
the NF-kB, IRF and AP1 families (10,11). Class I TFs
induce primary-response genes in a rapid (1–2 h) and
protein-synthesis independent manner (10,11). Primary-
response genes include genes encoding TFs (class II TFs)
governing subsequent waves of transcriptional responses
(10–13). Class II TFs induce secondary responses and/or
modulate primary responses. Class I and II TFs collabo-
rate with cell-type-specific TFs (class III TFs), certain of
which––such as PU-1, RUNX1 or C/EBP––are believed
to function as ‘pioneer’ factors that establish an accessible
chromatin environment at regulatory elements of inducible
genes (8,10,11,14–16).
Compared to current knowledge on TF networks gov-
erning transcriptional activation in DCs, little is known
about mechanisms controlling maturation-induced tran-
scriptional silencing. Certain class II TFs––such as ATF3,
BCL6 andPRDM1––function as repressors that dampen or
terminate transcriptional responses in activated DCs (17–
19). However, virtually nothing is known about primary-
response mechanisms mediating silencing during early
stages of DC maturation. Yet large-scale expression-
profiling studies have indicated that numerous genes are
down-regulated rapidly in response to maturation stim-
uli (7,8). Mechanisms underpinning this large-scale gene-
silencing have not been investigated. One reason for this is
that our general comprehension of mechanisms regulating
inducible gene-silencing is remarkably poor relative to those
governing transcriptional activation. Another reason is that
mRNA-stability issues confound the temporal analysis of
transcriptional silencing bymRNA-expression profiling ap-
proaches.
Silencing of specific genes is known to be critical
for the function of mature DCs. Notable examples are
provided by MHCII-mediated Ag-presentation: silencing
of the ubiquitin-ligase MARCH1 stabilizes cell-surface
MHCII expression (20) whereas silencing of the MHCII-
transactivator CIITA aborts de novoMHCII synthesis (21).
These processes promote cell-surface retention of peptide-
MHCII complexes presenting Ags captured prior to DC-
activation. To study maturation-induced repression in DCs,
we first focused on the CIITA gene. CIITA silencing was
found to be a highly sensitive primary response triggered
in human and mouse DCs by diverse maturation signals,
and involves rapid histone-deacetylation over a large chro-
matin domain. Genes subjected to the same silencing mech-
anismwere next identified by combining genome-wide anal-
yses of histone-deacetylation with a global quantification of
nascent transcripts. This identified numerous genes under-
going chromatin-deacetylation and transcriptional-arrest
within 1 h. Promoters of these genes are strongly en-
riched in PU.1-binding sites, suggesting a new role for this
TF in marking genes poised for repression. The repressed
genes are implicated in key functions––including Ag cap-
ture and presentation, extracellular-signal detection, signal
transduction and lipid-mediator synthesis––underscoring
the pivotal contribution of primary silencing to DC mat-
uration.
MATERIALS AND METHODS
Cells
Mo-DCs were generated as described (21). Their matura-
tion was induced with lipopolysaccharide (LPS) (Alexis,
25 ng/ml unless indicated otherwise), polyI:C (Amersham
Biosciences, 0.05 mg/ml), peptidoglycan (PGN, Sigma, 10
g/ml), Pam3CysSerLys4 (PAM3CSK4, InvivoGen, 500
ng/ml), TNF (InvivoGen, 100 ng/ml) or flagellin (Invivo-
Gen, 200 ng/ml). DC2114 cells were activated with CpG as
described (22,23). Cells were treated with 165 nM Tricho-
statin A (TSA, Sigma-Aldrich) or 0.4 mM Cycloheximide
(CHX, Sigma-Aldrich). SP600125, SB202190, Lactacystine
and U0126 were from Calbiochem.
qRT-PCR
Total and nascent RNA extractions, and cDNA synthesis,
were done as described (24,25). Quantification was done
using the iCycler iQ Real-Time polymerase chain reaction
(PCR) Detection System (Biorad) and a Sybr-Green-based
kit for quantitative PCR (iQ Supermix Biorad). Results
were normalized using 18S rRNA. Primer sequences are
available upon request.
Western blotting
Protein extracts were fractionated by Sodium
dodecylsulphate-polyacrylamide gel electrophoresis
and western blotting was performed using the following
antibodies: MARCH1 (Abcam), CLEC10A (Abnova),
SOCS5 (GeneTex), CLEC4A (GeneTex) and tubulin
(SIGMA-ALDRICH).
Chromatin immunoprecipitation (ChIP)
ChIP experiments were performed as de-
scribed (24) using antibodies against H4Ac (Up-
state Biotechnology/Millipore), H3Ac (Upstate
Biotechnology/Millipore), H3K4trim (Abcam), RNA
pol II (Abcam) and PU-1 (Santa Cruz). Results were quan-
tified by real-time PCR using the iCycler iQ Real-Time
PCR Detection System (Biorad) and a Sybr-Green-based
kit for quantitative PCR (iQ Supermix Biorad). Primer
sequences are available upon request.
ChIP-chip experiments
Three biological replicates ofH4Ac-ChIP samples were pre-
pared from immature Mo-DCs and Mo-DCs stimulated
for 1 h with LPS, and verified by quantitative PCR to
assess LPS-induced H4-deacetylation at the CIITA locus.
DNA was purified, amplified by LPMCR as described (24)
and sent to Roche-NimbleGen for probe preparation and
hybridization to HG18 arrays carrying promoter regions
(∼−3.5 to +0.75 kb relative to the TSS) of all human genes,
or to a custom array of our own design (24). The latter
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carries unique sequences from the entire extended human
MHC locus (7.7 Mb on chromosome 6, genomic coordi-
nates 26.1 to 33.8 Mb in hg17) and selected control re-
gions (total 0.9 Mb). Genomic loci are covered at high den-
sity with overlapping Tm-matched oligonucleotides (∼50
bp long) spaced such that their 5′ ends are ∼10 bp apart.
Data derived from the promoter arrays was analyzed for
peaks using NimbleScan software.
Nascent RNA extraction
Nascent RNA was isolated essentially as described (21,25).
10–20 × 106 Mo-DCs were washed thrice with phosphate
bufferedsaline and resuspended in 10% glycerol, 0.3 M su-
crose, 60 mM KCl, 15 mM NaCl, 15 mM HEPES (pH
7.9), 0.5mMEthylenediaminetetraacetic acid (EDTA), 0.15
mM Spermine, 0.5 mM Spermidine, 0.5 mM PMSF, 1 mM
Dithiothreitol (DTT). Cells were lysed for 10 min on ice
after adding one volume of the same solution containing
0.8% NP40. Nuclei were pelleted through a 1 ml cushion of
the same solution containing 0.9 M sucrose, resuspended in
75 mM NaCl, 20 mM Tris-HCL (pH 7.9), 0.5 mM EDTA
0.125 mM PMSF 0.85 mM DTT, 50% glycerol and lysed
for 10 min on ice after adding 8 volumes of 0.3 M NaCl, 20
mMHEPES (pH 7.6), 0.2 mMEDTA, 7.5 mMMgCl2, 1M
Urea, 1 mM DTT, 1% NP-40. Chromatin was pelleted by
centrifugation and resuspended in 500 l of 50 mM NaAc
(pH5), 50 mMNaCl, 0.5% sodium dodecyl sulphate (SDS).
Nascent RNA was purified by three extractions with hot
phenol (saturated with 50 mM NaAc pH5, 50mM NaCl)
and precipitated with 0.15 M NaCl and ethanol. RNA was
resuspended in 50l 10 mMTris-HCL (pH 7.6) and treated
with DNaseI for 15 min at 37◦C in 10 mM MgCl2, 1 mM
DTT.DNase activitywas stopped by adding 50mMEDTA,
1.5 M NaAc, 1% SDS and RNA was purified by phenol-
chloroform extraction and ethanol precipitation. Nascent
RNA samples were depleted of ribosomal RNA (rRNA)
using the Ribominus kit (Invitrogen). Nascent RNA sam-
ples corresponding to three independent experiments were
subjected to quality controls by qRT-PCR. DNA contami-
nation was excluded by omitting reverse transcriptase.Mat-
uration was assessed by measuring IL12B, IL1B and TNF
mRNAs induction. Enrichment of primary transcripts was
verified using primers specific for selected unspliced precur-
sor RNAs. rRNA depletion (typically >95%) was verified
using primers for 18 and 28S RNAs.
RNA sequencing
cDNA libraries were generated from three independent
nascent RNA or mRNA samples using Illumina specifi-
cations. Illumina technology was used to generate paired-
end reads (80 bp) for nascent RNA or single-end reads
(50 bp) for mRNA. Data analysis consisted of a fil-
tering step to eliminate reads consisting mono- and di-
nucleotide repeats followed by the identification of exact
unique matches using fetchGWI (26). Megablast was used
to recover unmatched reads (http://www.ncbi.nlm.nih.gov/
blast/html/megablast.html). Paired information was used to
generate alignments of each read on the genomic region
where hits were found by previous steps using SIBsim4 http:
//sibsim4.sourceforge.net/. Alignments were analyzed using
Tromer (27).
ChIP sequencing
10 ng of immunoprecipitated-DNA or chromatin-input-
DNA were used to prepare sequencing libraries us-
ing Illumina specifications. 50-nucleotide single-end reads
were generated using Illumina technology. Reads were
aligned to the reference human genome GRCh37.71 using
Bowtie version 0.12.7 (http://bowtie-bio.sourceforge.net/
index.shtml). Only uniquely mapped reads were considered
for further analysis. Peaks were called using MACS soft-
ware version 2.0.10.20130520 (http://liulab.dfci.harvard.
edu/MACS/). Input-DNA was used as background con-
trol. Peaks were considered significant if theirP-values were
<10−5 and if present (overlapping by >1 nt) in two biolog-
ical repeats.
TFBS enrichment
Pscan was used to identify potential TF-binding-sites (TF-
BSs) (JASPAR database) that are overrepresented between
nucleotides −450 and +50 relative to the TSS (http://159.
149.160.51/pscan/). TFBSs with P-values <10−3 were con-
sidered to be significantly overrepresented.
Gene ontology
Gene ontology analyses were performed at http://david.
abcc.ncifcrf.gov/ and http://cbl-gorilla.cs.technion.ac.il/.
RESULTS
Silencing of CIITA
CIITA mRNA abundance is decreased during DC mat-
uration (19,21,28). To clarify the mechanism involved,
CIITA-silencing was investigated in human monocyte-
derived DCs (Mo-DCs). CIITA-silencing was induced
by diverse stimuli––including LPS, tumor necrosis fac-
tor (TNF), peptidoglycan (PGN), Pam3CysSerLys4
(PAM), polyinosinic-polycytidylic acid (pIC) and flagellin
(Flag)––indicating that it is a general feature of Mo-
DC maturation (Figure 1A). Time-course experiments
demonstrated that LPS-induced down-regulation of CIITA
mRNA was detectable by 1 h and reached baseline levels
by 2 h (Figure 1B). This decrease preceded the induction
of IL12B (Figure 1B) and IL6 (data not shown) mRNAs.
LPS-concentrations as low as 0.25 ng/ml were sufficient
to trigger CIITA-silencing, whereas higher concentrations
were required for optimal induction of IL12B (Figure 1C)
and IL6 (data not shown) mRNAs. Quantification of
chromatin-bound nascent transcripts demonstrated that
LPS-induced down-regulation of CIITA mRNA resulted
from an arrest in transcription that was evident by 15 min
and almost complete after 1 h (Figure 1D). Quantitative
chromatin-immunoprecipitation (qChIP) experiments
revealed a rapid LPS-induced disengagement of RNA-
polymerase-II (pol-II) at the DC-specific promoter (pI) of
CIITA (Figure 1E).
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Figure 1. Transcriptional silencing of CIITA during DCmaturation. (A) CIITAmRNAwas quantified inMo-DCs exposed for 24 h to LPS, TNF, PGN,
PAM, pIC or Flagellin. Results are represented relative to unstimulated DCs. Statistical significance was derived from three experiments: *, P < 0.05
(B) CIITA and IL12B mRNAs were quantified in Mo-DC treated with LPS for the indicated times. Results are represented relative to unstimulated DCs.
Statistical significance was derived from three experiments: *,P< 0.05, **,P< 0.01, ***,P< 0.001. (C) CIITA and IL12BmRNAs were quantified inMo-
DCs treated for 6 h with the indicated LPS concentrations. Results are expressed relative to unstimulated DCs. Results are derived from two experiments.
(D) Nascent CIITA transcripts were quantified in Mo-DCs exposed to LPS for the indicated times. Results are expressed relative to unstimulated DCs.
Results are derived from two experiments. The data is representative of four experiments. (E) Binding of Pol-II to CIITA promoter I and a 26 kb upstream
region (background control) was assessed by qChIP in Mo-DCs exposed to LPS for the indicated times. Results are expressed relative to immature DCs at
CIITA promoter I. Statistical significance was derived from three experiments: *, P< 0.05. (F) H4Ac was measured in Mo-DCs activated with LPS for the
indicated times at the indicated positions of CIITA. Results are expressed relative to H4Ac at promoter IV in immature DCs. Results are derived from two
experiments. The data is representative of four experiments. (G) H4Ac-profiling at the CIITA,HLA-B and IL4 genes was performed by ChIP-chip. H4Ac
in untreated Mo-DCs (blue) was determined as the signal ratio between immature DCs (iDC) and input DNA. H4-deacetylation (red) was determined as
the signal ratio between iDCs and DCs exposed to LPS for 1 h. Ratios are represented on a log2 scale. Maps of the genes are shown below: the scale in kb
and TSSs are indicated. (H) CIITA mRNA was quantified in Mo-DCs treated with LPS for 4 h in the absence or presence of TSA. Results are expressed
relative to immature DCs. Results are derived from two experiments. The data is representative of four experiments. All measurements were performed in
triplicate for each experiment.
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The contribution of epigenetic mechanisms to CIITA-
silencing was assessed by qChIP experiments using anti-
bodies against histone modifications characteristic of ac-
tive or repressed chromatin. Active-chromatin marks exam-
ined were histones H3 and H4 acetylation (H3Ac, H4Ac),
and H3-lysine-4 trimethylation (H3K4trim). Repressed-
chromatin marks examined were H3-lysine-9 dimethylation
andH3-lysine-27 trimethylation. Deposition of heterochro-
matin protein (HP1) was also examined. These chromatin
features were assessed in LPS-treated Mo-DCs at strate-
gic positions in the regulatory region of CIITA. Strong re-
ductions in H4Ac were observed at all four CIITA pro-
moters (pI–pIV) and at a position situated 4 kb down-
stream of pIV (Figure 1F). H4-deacetylation was evident
after 15 min (Figure 1F). A similar, albeit less marked,
reduction in H3Ac was observed (Supplementary Figure
S1A). H3K4trim was also decreased (Supplementary Fig-
ure S1A), but this was a secondary event occurring at later
time points (24 h).No significant changes in repressive chro-
matin marks or HP1 deposition were observed during the
same time frame (data not shown). H4-deacetylation was
thus the most characteristic change associated temporally
with CIITA-silencing.
ChIP-on-microarray (ChIP-chip) experiments were per-
formed to analyze H4-deacetylation at the CIITA locus in
greater detail. H4Ac-ChIP samples prepared from imma-
ture Mo-DCs and 1 h-LPS-treated Mo-DCs were used to
probe a custom-made high-density array carrying the en-
tire CIITA locus and control genes (24). Input DNA was
used as control. The immature-DC/input-DNA signal ra-
tio was used to assess the initial pattern of H4Ac in imma-
ture Mo-DCs. H4-deacetylation was assessed by determin-
ing the immature-DC/LPS-treated-DC signal ratio. 1 h of
LPS treatment induced removal of the H4Ac mark over a
large 40–50 kb region spanning the entire regulatory region
of CIITA (Figure 1G). Deacetylation was not observed at
control genes, such asHLA-B, which is not silenced, or the
non-expressed IL4 gene (Figure 1G).
Functional relevance of histone deacetylation for CIITA
silencing was investigated by using the histone-deacetylase
(HDAC) inhibitor Trichostatin A (TSA). TSA impaired
LPS-induced CIITA mRNA down-regulation, suggesting
that CIITA silencing requires histone deacetylation (Fig-
ure 1H).
The rapid kinetics of CIITA silencing suggested that
it is a primary response triggered by pre-existing signal-
transduction pathways. This was confirmed by the finding
that it was not abrogated by the protein-synthesis inhibitor
cycloheximide (Figure 2A). Selective inhibitors were used
to identify signal-transduction pathways mediating CIITA
silencing (Figure 2A). Efficacy of the inhibitors was con-
trolled by qRT-PCR experiments examining the expression
of genes induced via the targeted pathways andwestern-blot
experiments examining phosphorylation of signaling inter-
mediates (data not shown). Inhibitors of NF-B activation,
including lactacystine (Figure 2A) and MG-132 (data not
shown) had no impact onCIITA silencing. Inhibitors of the
c-Jun N-terminal kinase JNK (SP600125), p38 (SB202190)
and extracellular signal-regulated kinases ERK (U0126)
MAPK pathways also had no impact when added individ-
ually. However, CIITA silencing was completely abrogated
by blocking both the p38 and ERK pathways (Figure 2A).
Key features of the CIITA-silencing process were investi-
gated in the mouse DC2114 cell line (22,23) stimulated with
CpG. Rapidmaturation-induced silencing of theCIIta gene
was evident at the mRNA (Figure 2B) and nascent tran-
script (Figure 2C) levels, sensitive to lower doses of CpG
than required for optimal IL6 induction (Figure 2D), and
associated with rapid histone-deacetylation within its reg-
ulatory region (Figure 2E, Supplementary Figure S1B). Si-
lencing ofCIIta in mouse BM-DCswas previously reported
to involve the p38 and ERK pathways (28).
CIITA silencing is representative of a global transcriptional
remodeling response
To identify additional genes subjected to the same silenc-
ing process as CIITA, H4Ac-ChIP samples from imma-
ture Mo-DCs and 1 h-LPS-treated Mo-DCs were used
to probe genomic arrays carrying a comprehensive set of
human promoters (Figure 3A). ∼1000 promoters (∼4%)
exhibited strong and reproducible H4-deacetylation (Fig-
ure 3A, Supplementary Figure S2A). Promoters exhibiting
H4-deacetylation were more numerous than those display-
ing increasedH4Ac (Figure 3A,∼1%). The spatial distribu-
tion of deacetylated regions revealed a preference for posi-
tions close to the transcription-start-site (TSS, Supplemen-
tary Figure S2C). ChIP-chip experiments performed with
our custom array confirmed that H4-deacetylation affected
regions upstream of the TSSs of representative genes (Sup-
plementary Figure S2B).
Gene-ontology analyses revealed that genes displaying
promoter-deacetylation are significantly enriched in func-
tions of high relevance for the immune system and DC bi-
ology (Figure 3B). For a selection of such functionally rel-
evant genes, H4 and H3 deacetylation in 1 h-LPS-treated
Mo-DCs was confirmed by qChIP experiments (Figure 3C
and data not shown).
Key features of the silencing mechanism documented
for CIITA were investigated for selected genes. Quantifi-
cations of nascent transcripts and Pol-II occupancy indi-
cated that all tested genes exhibited rapid transcriptional
downregulation and pol-II disengagement after 1 h of LPS
exposure (Figure 3C). Downregulated genes exhibited a 2
to 20-fold reduction in transcription. LPS-induced tran-
scriptional silencing preceded mRNA decay (Supplemen-
tary Figure S3A) and reduced protein expression (Supple-
mentary Figure S3B) at representative genes. TLR ligands
other than LPS also induced silencing (Supplementary Fig-
ure S2D). Finally, for selected genes, such as IFNGR1, it
was confirmed that silencing is induced by low LPS con-
centrations (Supplementary Figure S3C) and blocked by
combined inhibition of the ERK and p38 pathways (Sup-
plementary Figure S3D).
Rapid transcriptional silencing of deacetylated genes
To assess global transcriptional consequences of histone-
deacetylation, we explored the possibility of exploiting pub-
lished microarray-based mRNA-expression data. A com-
parison of seven datasets for LPS-treated Mo-DCs (29–
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Figure 2. CIITA silencing is a conserved primary response mediated by the p38 and ERK pathways. (A) CIITA mRNA was quantified in immature and 4
h-LPS-treated Mo-DCs in the presence of the indicated concentrations of cycloheximide (CHX), Jun kinase inhibitor SP600125, p38 inhibitor SB202190,
NF-B inhibitor lactacystin, ERK inhibitor U0126 and U0126 + SB202190. Results are represented relative to immature DCs. Results are derived from
two experiments. (B) CIITA mRNA was quantified in DC2114 cells exposed to CpG for the indicated times. Results are presented relative unstimulated
DCs. Results are derived from two experiments. (C) Nascent CIITA RNA was quantified in DC2114 cells. exposed to CpG for the indicated times. Results
are presented relative unstimulated DCs. Statistical significance was derived from three experiments: *, P < 0.05, **, P < 0.01, ***, P < 0.001. (D) CIITA
and Il6 mRNAs were quantified in DC2114 cells treated for 6 h with the indicated concentrations of CpG. Statistical significance was derived from three
experiments: *, P < 0.05, **, P < 0.01. (E) H4Ac was measured in DC2114 cells activated with CpG for the indicated times at the indicated positions of
the CIIta gene. Results are expressed relative to H4Ac at promoter IV in immature DCs. Statistical significance was derived from three experiments: *, P
< 0.05, **, P < 0.01, ***, P < 0.001. All measurements were performed in triplicate for each experiment.
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Figure 3. Identification of promoters undergoing H4-deacetylation upon Mo-DC maturation. (A) Schematic representation of the ChIP-chip strategy
used to identify promoters that are deacetylated in Mo-DCs after 1 h of LPS treatment (top). Representative results for CIITA, IL12B, ACTB, CD1C,
CD36 and CLEC4A are provided: signal ratios between 1 h-LPS-treated and untreated Mo-DCs are represented on a log2 scale (bottom left). The per-
centages of promoters displaying increased or decreased H4Ac are shown (bottom right). (B) Gene-ontology analysis of genes exhibiting LPS-induced
H4-deacetylation at their promoters was done using David (http://david.abcc.ncifcrf.gov/). (C) H4-deacetylation (top), nascent transcripts (middle) and
pol-II occupancy (bottom) were quantified for the indicated genes in untreated and 1 h-LPS-treated Mo-DCs: results are expressed relative to untreated
DCs; nt, not tested. Statistical significance was derived from three experiments: *,P< 0.05, **,P< 0.01, ***,P< 0.001. All measurements were performed
in triplicate for each experiment.
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32) indicated that mRNA-profiling is not reliable for study-
ing gene silencing. Reproducibility was significantly lower
for silenced genes than induced genes: whereas most in-
duced genes (75%) were reproduced in at least two exper-
iments, most down-regulated genes (60%) were observed
in only one experiment (Supplementary Figure S3E). Fur-
thermore, key genes silenced in activated Mo-DCs, includ-
ing CIITA, MARCH1 and CD1A (Figure 1, Figure 3C
and Supplementary Figure S3A and F) (20,21), were not
found to be down-regulated in the microarray experiments,
probably because of low expression-levels and/or mRNA
half-life issues. We therefore developed a genome-wide ap-
proach for measuring global transcription rates, based on
high-throughput sequencing of chromatin-bound primary
transcripts (Figure 4A). Primary-transcript and mRNA
preparations from immature Mo-DCs and 1 h-LPS-treated
Mo-DCs were sequenced in parallel. Reproducibility be-
tween biological repeats was excellent as evidenced by ex-
amining global transcription profiles (Supplementary Fig-
ure S4A), spatial patterns of sequence-reads mapping to in-
dividual genes (Supplementary Figure S4B), and transcrip-
tional changes observed for representative genes (Supple-
mentary Figure S4C).
Three lines of evidence confirmed that the procedure
quantifies primary transcripts. First, primary-transcript-
reads mapped to the introns and exons of individual genes,
whereas mRNA-reads mapped exclusively to exons (Fig-
ure 4B and C). Second, nascent-transcript-reads mapped
to entire microRNA genes, not just mature-microRNA se-
quences (Figure 4C). Third, silencing was readily detectable
for individual genes after 1 h of LPS treatment, well before
decreased mRNA abundance was evident (Supplementary
Figure S3A).
Examinations of selected genes indicated that nascent-
transcript sequencing allows reliable quantification of tran-
scription rates at genes that are silenced or induced
in 1 h-LPS-treated Mo-DCs, including protein-coding
and microRNA genes (Figure 4B, C and Supplemen-
tary Figure S4C). Global analyses indicated that markedly
more changes in expression were evident at the primary-
transcript level than at that of mRNA-abundance (Fig-
ure 5A and Supplementary Table S1). Significantly more
genes were down-regulated at the nascent transcript level
than at the mRNA level (Figure 5B and Supplementary
Table S1), suggesting that most reductions in transcription
rate induced by 1 h of LPS stimulation do not yet have a
major impact on mRNA abundance. These results demon-
strate that assessing gene silencing by nascent-transcript se-
quencing is significantly more reliable and has strongly im-
proved temporal resolution compared to mRNA-profiling.
Eight hundred forty-seven (85%) of the genes subjected
to rapid histone-deacetylation were expressed in immature
Mo-DCs above a baseline level of 1 read per kb per mil-
lion (RPKM) (Figure 5C). 590 (70%) of these genes ex-
hibited >2-fold reduction in transcription rate after 1 h
of LPS treatment, including all genes for which silencing
was validated by qRT-PCR (Figure 5C and Supplementary
Table S1). Reductions in transcription ranged from 2 to
nearly 100-fold (Figure 5C), indicating that the repressed
genes comprise genes that are turned off and genes that
are down-modulated. As inferred from the global analyses
(Figure 5B), reductions in mRNA abundance were not yet
evident for most deacetylated-silenced genes (Figure 5C).
PU.1-occupied sites mark silenced genes
Insight into the silencing mechanism was gained by an-
alyzing predicted TFBSs. TFBS-enrichment was investi-
gated in genes that are induced, unchanged in their ex-
pression, or deacetylated and silenced (Figure 5D). In-
duced genes were characterized by a strong enrichment in
NF-B TFBSs (Figure 5D, E and Supplementary Table
S2). In sharp contrast, TFBSs for ETS-family members
were strongly enriched in deacetylated-silenced genes (Fig-
ure 5D, E and Supplementary Table S2). Both patterns of
TFBS-enrichment differedmarkedly from that observed for
genes that are unchanged in their expression (Figure 5D).
The different patterns of TFBS-enrichment suggest that
the three sets of genes are controlled by distinct regulatory
mechanisms.
PU.1 is the most strongly expressed ETS-family mem-
ber in Mo-DCs (Figure 6A and Supplementary Table S2).
ChIP-sequencing experiments were performed tomap PU.1
binding in Mo-DCs. The distribution of PU.1-bound sites
was compared between the promoter regions of genes that
are deacetylated-silenced, induced or unchanged in their ex-
pression in response to LPS (Figure 6B). The promoters of
all human genes were used as baseline. PU.1-occupied sites
were more frequent relative to baseline in all three subsets,
distributed symmetrically upstream and downstream of the
TSS, and enriched most strongly near the TSS. Surpris-
ingly, PU.1-bound sites were most frequent in deacetylated-
silenced genes. Binding was not affected by LPS treatment
at most positions, indicating that silencing is not due to
PU.1-disengagement (Supplementary Figure S5).
Functions affected by epigenetic silencing
Gene-ontology analyses demonstrated that genes subjected
to silencing are strongly enriched in immune-system pro-
cesses, including numerous genes implicated in DC func-
tion (Figure 3B and Supplementary Table S3). The most
relevant processes include Ag uptake and presentation,
extracellular-signal detection, signal transduction, lipid
metabolism, cell migration and cytokine production (Fig-
ure 7 and Supplementary Table S3, see ‘Discussion’ sec-
tion). Although down-regulated expression during DC-
maturation was reported for certain genes, such as CIITA,
MARCH1 and CD36 (20,21), for the majority this has not
been documented. Rapid epigenetic silencing is thus a newly
identified mechanism that concerns numerous functionally
relevant genes andmakes amajor contribution to transcrip-
tional reprogramming of DCs at an early stage of the mat-
uration process.
DISCUSSION
Analysis of CIITA silencing led to the identification of a
novel silencing mechanism that makes a substantial con-
tribution to reshaping of the transcription program dur-
ing DC maturation. This mechanism is conserved be-
tween humans and mice, triggered by multiple matura-
tion stimuli, dependent on combined activation of the p38
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Figure 4. Transcriptome profiling by nascent-transcript sequencing. (A) Schematic representation of the strategy used for purifying and sequencing
chromatin-bound nascent transcripts. mRNA was purified and sequenced in parallel. (B and C) Nascent-transcript-sequencing profiles are shown for
representative silenced (B) and induced (C) genes: results are expressed as numbers of reads mapping to the genes in untreated and 1 h-LPS-treated Mo-
DCs; schematic maps of the genes are depicted; exons are indicated as boxes; positions of mature microRNA sequences are indicated for microRNA genes;
mRNA-sequencing profiles from untreated Mo-DCs are included as controls for protein-coding genes.
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Figure 5. Characterization of nascent-transcript-sequencing data. (A) The dot plots show a global analysis of altered nascent-transcript (left) and mRNA
(right) expression induced in 1 h-LPS-treated Mo-DCs: results are represented as RPKM (reads per kb per million) on a log scale; induced (>2x), silenced
(>2x) and unchanged genes are represented as green, red and black dots, respectively. (B) The dot plot compares changes in nascent-transcript and mRNA
expression induced in 1 h-LPS-treated Mo-DCs: results are represented as fold change on a log scale; genes that are induced (>2x), silenced (>2x) and
unchanged at the nascent-RNA level are represented as green, red and black dots, respectively. (C) The pie chart shows the percentage of deacetylated genes
expressed more than 1 RPKM in immature Mo-DCs. The dot plot shows 1 h-LPS-induced changes in nascent-transcript (red dots) and mRNA (black
dots) expression for deacetylated genes; genes are ordered with respect to their change in nascent-transcript expression; positions of representative genes
are highlighted. (D) TFBS enrichment analyses were performed for promoters of genes that are induced (>2, 3 or 5-fold), deacetylated and silenced (>2, 3
or 5-fold), or exhibit no change (nc) in expression in Mo-DCs after 1 h of LPS treatment. TFBSs were defined according to JASPAR. The heat map shows
the relative enrichment (z-score) of TFBSs that are significantly over-represented (P-value < 10−3). (E) The graphs summarize the z-scores and P-values
for all TFBSs in genes that are induced>3-fold (top) or deacetylated and silenced>3-fold (bottom): NF-B (green) and ETS (red) TFBSs are highlighted.
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Figure 6. Mapping of PU.1-binding inMo-DC. (A) Relative expression (mRNA-sequencing) of mRNAs encoding ETS family members in immatureMo-
DCs. (B) PU.1-ocuppied sites (ChIP-sequencing) were analyzed in the promoter regions of genes that are deacetylated and silenced >5-fold (left column),
induced >5-fold (center column), or exhibit no change in expression (right column) in Mo-DCs after 1 h of LPS treatment. Panels show the percent of
genes having at least 1 PU.1 peak within a window of the indicated size centered on the TSS (first row), the percent of genes containing at least 1 PU.1 peak
within the indicated distance upstream or downstream of the TSS (second row), heat maps indicating the positions of PU.1 peaks (black lines) within 4 kb
regions centered on the TSS (third row) and the percent of genes having at least one PU.1 peak situated at the indicated distance upstream or downstream
of the TSS (bottom row). In all graphs, the entire set of human genes was used as baseline reference. RPKM, reads per kb per million.
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Figure 7. Functional relevance of rapid transcriptional silencing in activated DCs. (A) Schematic summary of signal-transduction pathways and functional
consequences triggered by TLR-engagement in DCs: our results define a novel primary silencing pathway that is distinct from known gene induction
mechanisms and modulates key processes during DCmaturation. The silencing mechanism affects the expression of pivotal proteins (red boxes) implicated
in: (B) TLR signaling (MKK6), (C) CLR signaling (SYK), (D) PI3K-Akt signaling (PI3K) and (E) icosanoid biosynthesis (LTA4H, 15-LOX, COX1).
and ERKMAPK signal-transduction pathways, associated
with extensive histone-deacetylation over large regulatory
domains, and leads to transcriptional silencing of hundreds
of genes, many of which have functions of central relevance
for DC biology. The extent of repression is variable, rang-
ing from genes that are moderately down-regulated to genes
that are essentially turned off.
Several methods for analyzing gene-expression profiles
directly at the level of transcription have been reported
(7,33,34). We developed a simple and robust procedure sim-
ilar to that recently reported elsewhere (7). This method
relies on high-throughput sequencing of chromatin-bound
primary transcripts. It proved to be highly reliable for mea-
suring rapid changes in transcription-rates with a high de-
gree of sensitivity and temporal resolution. It is particularly
valuable for dissecting dynamic transcriptional silencing
mechanisms, which is difficult to achieve by mRNA quan-
tification, particularly for mRNAs having long half-lives.
Furthermore, identifying sets of genes that are repressed in
a temporally coordinated manner cannot be achieved reli-
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ably by mRNA-expression profiling because distinct mR-
NAs can have substantially different stabilities.
The silencingmechanism described here constitutes a pri-
mary response that is independent of de novo protein syn-
thesis and essentially complete within 1 h. These features
distinguish it from repression mechanisms operating dur-
ing later stages of DC maturation, such as the dampen-
ing or termination of gene expression by the class II TFs
ATF3, BCL6 and PRDM1 (17–19). It also precedes the
establishment of epigenetic modifications that repress in-
ducible cytokine-gene expression at late stages of myeloid
cell activation, such as those implicated in conferring endo-
toxin tolerance in activated macrophages (35).
Promoters of induced genes are characterized by an in-
creased frequency of NF-BTFBSs. In contrast, genes sub-
jected to silencing exhibit an under-representation of NF-
B TFBSs and a high frequency of TFBSs for ETS-family
members. The under-representation ofNF-B-binding sites
is consistent with the observation that silencing is indepen-
dent of NF-B activation. However, an increased frequency
of ETS-family TFBSs in silenced genes was unexpected.
ChIP-seq experiments confirmed that PU.1-bound sites
are most frequent in the promoters of silenced genes. In
mice, Pu.1 is a lineage-specification TF playing critical roles
in hematopoiesis, including the development ofmyeloid and
lymphoid cells (36,37). Conditional gene-deletion demon-
strated that Pu.1 is required for the development of all DC
subsets (38). Genome-wide binding studies performed in
various cell types, including DCs, have suggested that Pu.1
functions as a ‘pioneer’ factor that establishes a permissive
chromatin landscape at enhancers controlled by lineage-
specific and inducible TFs (14,15). Given this function, the
finding that PU.1-bound sites are more frequent in promot-
ers subjected to inducible repression than in inducible or
constitutive promoters was unanticipated and suggests a
novel role for this TF, namely that it marks genes poised
for inducible silencing. This is consistent with reports im-
plicating PU.1 in the repression of specific genes (39). It has
notably been suggested to repress promoter I of CIITA in
mouse and human DCs (19). Repression by PU.1 has been
attributed to its ability to recruit HDACs (40,41), a mecha-
nism consistent with the finding that histone-deacetylation
is the primary event associated with the silencing pro-
cess we have unveiled. However, we have been unable to
demonstrate selective recruitment of specific HDACs to
deacetylated-silenced promoters during Mo-DC matura-
tion (data not shown).
The silencing mechanism is anticipated to have pro-
found impacts on Ag capture, processing and presenta-
tion. First, the silencing process leads to increased cell-
surface MHCII expression and reduced de novo MHCII
synthesis. Enhanced cell-surface MHCII expression results
from down-regulation of the E3 ubiquitin ligaseMARCH1,
which increases MHCII turnover by promoting their ubiq-
uitination and degradation (20,42). Decreased MHCII-
synthesis is due to abrogated CIITA expression (21). Con-
comitant silencing of the MARCH1 and CIITA genes en-
sures that MHCII-restricted Ag presentation focuses on
Ags captured prior to DC-activation. Second, reduced ex-
pression of the endocytic adaptors Epsin-1 and Epsin-2 is
expected to hinder clathrin-mediated endocytosis (43) and
could contribute to impaired Ag-uptake by mature DCs
(44). Third, silencing of genes encoding endocytic CLRs,
such as CLEC10A (encoding MGL, macrophage galac-
tose C-type lectin receptor), CLEC4A (encoding DCIR,
DC immune-receptor) and CLEC12A (encoding MICL,
myeloid inhibitory C-type lectin) is likely to impair Ag-
uptake in mature DCs. These CLRs bind glycans displayed
on pathogen or self-derived proteins, mediating their inter-
nalization and delivery to Ag-loading compartments, and
promoting Ag-presentation to CD4+ T cells and cross-
presentation to CD8+ T cells (45). Fourth, down-regulation
of the scavenger receptor CD36 will impair phagocytosis of
pathogens and apoptotic cells (46,47). Fifth, silencing of the
gene encoding insulin-regulated-aminopeptidase (IRAP) is
likely to contribute to impaired cross-presentation by ma-
ture DCs (48). IRAP is an endosomal protease required
for cross-presentation because it generates peptides suit-
able for MHCI-mediated Ag presentation by catalyzing
amino-terminal trimming of peptides derived from internal-
ized proteins (48). Sixth, down-regulation of CD1A, CD1B,
CD1C and CD1E expression is anticipated to lead to re-
duced de novo presentation of lipid and glycolipid Ags, in a
manner analogous to reduced de novoMHCII synthesis. Fi-
nally, silencing of BTN3A1 expression will reduce presenta-
tion of phosphorylated Ags. BTN3A1 was recently demon-
strated to present phosphorylated Ags to V9V2 T cells
(49). In summary, the silencing mechanism described here
has a broad impact on Ag capture, processing, presentation
and cross-presentation, including effects on the presenta-
tion of peptide, lipid and phosphorylated Ags.
A second major function affected by the silencing mech-
anism is the ability to detect and respond to extracellu-
lar signals. First, silencing of the CCR1 and CCR5 genes
contributes to the chemokine receptor switch (induction
of CCR7, down-regulation of CCR1 and CCR5) allow-
ing mature DCs to exit peripheral tissues and home to
lymphoid tissues (50). Second, down-regulation of TLR1,
3, 4 and 5 is anticipated to reduce responsiveness to
pathogens and endogenous danger signals. Third, reduced
DCIR, MICL and MGL expression will reduce signaling
induced by these endocytic CLRs. The cytoplasmic tails
of DCIR and MICL contain ITIM motifs, which recruit
the SHP-1 and SHP-2 phosphatases, thereby inhibiting
TLR and CLR induced DC-maturation and inflammatory-
cytokine expression (45,51). Mgl engagement also exerts
an anti-inflammatory role in mouse models (45,51). Si-
lencing of DCIR, MICL and MGL may thus remove
an inhibitory influence on DC maturation and function.
Fourth, genes encoding pivotal components of three ma-
jor signal-transduction pathways are silenced. Spleen ty-
rosine kinase (SYK) plays a central role in signaling in-
duced by the engagement of many CLRs, such as Dectin-
1, Dectin-2 and Mincle, as well as in TLR4-induced sig-
naling (52). MAP-kinase-kinase 6 (MAP2K6) plays a cru-
cial role in the p38 MAPK cascade, which is activated by
TLR-engagement and required for DC maturation (29).
The p110 (PIK3CA) and p110 (PIK3CG) catalytic sub-
units of class I phosphoinositide-3-kinases play pivotal roles
in diverse receptor-induced signal-transduction pathways
(53). Collectively, the repression of genes encoding diverse
ligand-activated receptors and pivotal intracellular signal-
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ing molecules implies that the silencing process we have de-
fined induces profound remodeling of the responsiveness of
DCs to environmental signals.
A third process affected by the silencing mechanism
is lipid mediator production. Reduced prostaglandin-
endoperoxidase-synthesase-1 (PTGS1) expression will
impair the production of prostanoids. Decreased
leukotriene-A4-hydrolase (LTA4H) expression will
impair leukotriene-B4 (LTB4) synthesis. Silencing of
arachidonate-15-lipoxygenase (ALOX15) expression will
reduce the synthesis of several bioactive lipids, including
lipoxins. Reduced expression of these enzymes should
have a dramatic impact on lipid-mediator synthesis. The
functional consequences of this alteration are difficult to
predict, as lipid-biosynthesis pathways are complex and
lipid mediators can exert distinct pro-inflammatory and
immunosuppressive effects on diverse cell types. Knowl-
edge on the patterns of lipid-mediator production by DCs
remains fragmentary. Our results suggest that this aspect of
DC function has been neglected and requires investigation.
In conclusion, genes subjected to the silencing mech-
anism we have characterized are implicated in key bio-
logical processes. These notably include Ag uptake, pro-
cessing, presentation and cross-presentation, extracellular-
signal detection, intracellular signal-transduction and lipid-
mediator synthesis. Rapid maturation induced silencing
thus makes a major contribution to the remodeling of DC
function in response to activation signals.
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